TL;DR: Lavo Life Sciences is a Y Combinator Winter 2023 startup AI for drug formulation, currently inactive with a team of 3.
AI for drug formulation
Last verified:
Lavo Life Sciences runs simulations of drug molecules on computers. Pharma companies use these simulations to guide their experiments and ultimately save time and money in the lab. This will de-risk and expedite clinical trials and FDA approval.
Built by LemStudio
Yes. Lavo Life Sciences was funded by Y Combinator in the Winter 2023 batch. AI for drug formulation
Lavo Life Sciences runs simulations of drug molecules on computers. Pharma companies use these simulations to guide their experiments and ultimately save time and money in the lab. This will de-risk and expedite clinical trials and FDA approval.
Lavo Life Sciences was part of Y Combinator's Winter 2023 batch.
Lavo Life Sciences has a team of 3 people according to Y Combinator's directory.
Lavo Life Sciences is currently listed as Inactive with a team of 3 in Y Combinator's directory.
Loading interactive view…